Induced Pluripotent Stem Cells Market Forecast: Comprehensive Global Analysis 2023-2028

Dublin, Jan. 12, 2024 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cells: Global Markets 2023-2028" report has been added to's offering.

A groundbreaking research publication providing an in-depth overview and forecasts for the global market of Induced Pluripotent Stem Cells (iPSCs) has now been released. Offering invaluable insights into an expanding field, this report emphasizes the significant strides and market projections from 2023 to 2028 in iPSC applications and technologies.

With 34 data tables and a detailed narrative, the report analyzes the iPSC industry, assessing the compound annual growth rates and market dynamics that shape its trajectory. It methodically examines revenue growth prospects and explicates a market share analysis dissected by reprogramming method, application, derived tissue cell type, species, product function, end use, and geographic region.

Given the crucial influence of regulatory environments on the market’s expansion, the report meticulously evaluates these aspects to aid stakeholders in navigating this complex landscape. It goes further to spotlight the ongoing R&D efforts in the iPSC segment, highlighting new developments, pipeline products, and the fervent research activity that is propelling the industry forward.

Industry Growth Drivers & Restraints

The report also discusses the driving forces enhancing the market’s growth, identifying novel opportunities within the iPSC sector. Conversely, it addresses limiting factors, providing a balanced overview of challenges faced in the industry. The publication demonstrates how these dynamics impact future market trends and sales projections for iPSC research and clinical applications.

Focused Market Segments

In the context of emerging trends, the report pays particular attention to the application of iPSCs within drug discovery and development. It exhibits the use of iPSC technology in diverse processes such as pharmacotoxicity screening, lead generation, and 3D disease modeling. Additionally, it delves into the competitive landscape, presenting a market share analysis of leading suppliers and manufacturers based on product types and geography. A comprehensive patent analysis and research funding examination are also included to forecast the direction of growth and innovation in the iPSC market.

Covering four main geographic regions – The U.S., Europe, Asia-Pacific, and the Rest of the World (RoW), the report delineates the specificity of induced pluripotent stem cells across these territories, offering nuanced insights into regional market behavior and opportunities.

With an impressive compilation of data and strategic analysis, this report serves as an authoritative source for stakeholders, investors, and industry specialists involved in the iPSC market. It stands as a vital resource to comprehend current market trends, fostering informed decision-making, and spurring further advancements in the field of regenerative medicine and beyond.

  • Global Market Trends and Revenue Data
  • Key Manufacturer Profiles
  • Research and Development Activity in the iPSC Segment
  • Detailed Market Share Analysis

For those engaged with the realm of induced pluripotent stem cells, this report offers a comprehensive review of the market, while projecting future industry developments poised to shape the landscape through 2028.

Key Attributes:

Report AttributeDetails
No. of Pages121
Forecast Period2023 - 2028
Estimated Market Value (USD) in 2023$3.4 Billion
Forecasted Market Value (USD) by 2028$5.2 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • Pluripotency Factors
  • Research and Therapeutic Significance

Chapter 4 Market Dynamics

  • Market Drivers
    • Growing Research and Development in iPSCs
    • Increased Investment in the Biotechnology Industry
    • Rising Prevalence of Chronic Diseases
    • Use of iPSCs in Precision Medicine

Chapter 5 Induced Pluripotent Stem Cell Applications

  • Academic Research
  • Pharmaco-toxicological Screening
  • Drug Discovery and Development
  • Disease Modeling
  • Tissue Engineering
  • Cell Therapy
  • Emerging Technologies

Chapter 6 Induced Pluripotent Stem Cell Market Segmentation and Forecast

  • Market Overview
  • Generation of Induced Pluripotent Stem Cells
  • Application-based Market Overview
  • Induced Pluripotent Stem Cells Product Market
  • Induced Pluripotent Stem Cell-derived Tissue Cell Market
  • Induced Pluripotent Stem Cells and Their Derivative Cell Market, by Species
  • Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
  • Market for Induced Pluripotent Stem Cell-derived Cells, by Application
  • Market for Induced Pluripotent Stem Cells, by Product Function
  • Market for Induced Pluripotent Stem Cells, by End Use

Chapter 7 Induced Pluripotent Stem Cells Research Application Market

  • Induced Pluripotent Stem Cells Research Product Types
  • Major Players
  • Major Commercial Entities
  • Major Noncommercial Organizations
  • Market Shares and Projections

Chapter 8 Induced Pluripotent Stem Cell Contract Service Market

  • Induced Pluripotent Stem Cell Contract Service Types
  • Major Players
  • Market Shares and Projections

Chapter 9 Clinical Application Market Trend Analysis

  • Clinical Trials
  • Age-related Macular Degeneration
  • Ischemic Heart Disease
  • Parkinson's Disease
  • Graft-versus-host Disease (GvHD)
  • Spinal Cord Injuries
  • Corneal Repair
  • Cancer
  • Driving Forces
  • Limiting Factors
  • Technologies
  • Regulations
  • Market Acceptance
  • Clinical Efficiency

Chapter 10 Competitive Landscape

  • Mergers and Acquisitions
  • Strategic Alliances

Companies Mentioned

  • Addgene
  • Allele Biotechnology And Pharmaceuticals Inc.
  • Alstem
  • Applied Biological Materials
  • Applied Stemcell Inc.
  • ATCC
  • Axol Bioscience Ltd.
  • Bio-Techne Corp.
  • Bluerock Therapeutics
  • Bristol Myers Squibb
  • Cell Signaling Technology
  • Corning Inc.
  • Creative Bioarray‎
  • Fate Therapeutics
  • Fujifilm Cellular Dynamics
  • Genecopoeia Inc.
  • Gentarget Inc.
  • ID Pharma Co. Ltd.
  • Invivogen
  • Lonza Group Ltd.
  • Megakaryon Corp.
  • Merck
  • Ncardia
  • Newcells Biotech
  • Peprotech Inc.
  • Plasticell Ltd.
  • Promega Corp.
  • Promocell
  • Qiagen
  • Reprocell Inc.
  • Sciencell Research Laboratories
  • Stemcell Technologies‎
  • System Biosciences Inc.
  • Takara Bio USA
  • Thermo Fisher Scientific
  • Vertex Pharmaceuticals Inc.
  • Waisman Biomanufacturing

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Induced Pluripotent Stem Cells Market